Anish Thomas

Anish Thomas

Company: National Cancer Institute

Job title: Investigator

Bio:

I am a clinical researcher with a focus on small cell lung cancer (SCLC), one of the most aggressive human cancers. The goal of my research is to systematically develop more effective therapies for patients with SCLC and similar chemotherapy-refractory tumors by targeting key pathways involved in DNA replication, repair, and chromatin remodeling. I design and conduct phase I and phase II trials that examine strategies to determine how enhancing DNA replicative stress can best be used in the clinic in combination with existing therapies to improve patient outcomes. This work stems from my intramural and extramural collaborations with basic scientists, translational researchers, surgical pathologists and clinicians, all of whom are interested in various facets of SCLC- from understanding the biology of genomic instability, chromatin regulation, and immunomodulation in solid tumors to identifying cancer dependencies that drive responses

Seminars:

Panel Discussion: The Promise of ATR & Other Emerging DDR Targets 2:30 pm

Read more

day: Day One

Translating ATR & Emerging Targets to the Clinic 2:00 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.